These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21921460)

  • 1. [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients].
    Uchiyama S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):832-4. PubMed ID: 21921460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
    Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
    Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
    Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
    Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
    Shinohara Y; Katayama Y; Uchiyama S; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C;
    Lancet Neurol; 2010 Oct; 9(10):959-68. PubMed ID: 20833591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol shows promise as an alternative to aspirin for patients with ischaemic stroke.
    Hankey GJ
    Lancet Neurol; 2008 Jun; 7(6):469-70. PubMed ID: 18456559
    [No Abstract]   [Full Text] [Related]  

  • 7. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study.
    Matsumoto M
    Atheroscler Suppl; 2005 Dec; 6(4):33-40. PubMed ID: 16275125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
    Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
    Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of the safety of starting administration of low-dose aspirin and cilostazol in acute ischemic stroke.
    Fujita K; Komatsu Y; Sato N; Higuchi O; Kujiraoka Y; Kamezaki T; Suzuki K; Matsumura A
    Neurol Med Chir (Tokyo); 2011; 51(12):819-24. PubMed ID: 22198102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
    Nakagawa I; Park HS; Wada T; Yokoyama S; Yamada S; Motoyama Y; Kichikawa K; Nakase H
    Neurol Res; 2017 Aug; 39(8):695-701. PubMed ID: 28290236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
    Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
    Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.
    Qian Y; Bi Q
    Eur J Med Res; 2013 Dec; 18(1):53. PubMed ID: 24313983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
    Ueda H; Kido A; Matsuhisa S; Asawa K; Yoshida N; Tsujimoto M; Sasaki Y; Kuga Y; Yamasaki M; Ueda K; Shinohara S; Nishida Y
    Am Heart J; 2016 Mar; 173():134-42. PubMed ID: 26920606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
    J Am Heart Assoc; 2019 Aug; 8(15):e012652. PubMed ID: 31347430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
    Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
    Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: a pilot study.
    Nakamura T; Tsuruta S; Uchiyama S
    J Neurol Sci; 2012 Feb; 313(1-2):22-6. PubMed ID: 22014645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons.
    Huang HP; Lin WH; Chen SG; Chen LZ; Chen MY; Che CH
    Mol Neurobiol; 2017 Mar; 54(2):1456-1466. PubMed ID: 26846361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.
    Lee JH; Cha JK; Lee SJ; Ha SW; Kwon SU
    Eur J Neurol; 2010 Mar; 17(3):434-42. PubMed ID: 19922458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.